Nine Monthly Results Results Snapshot
Figures in Rs cr
Consolidate Nine Monthly Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
121.29
124.15
107.16
118.72
106.67
59.36
50.70
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
121.29
124.15
107.16
118.72
106.67
59.36
50.70
Raw Material Cost
58.18
59.64
53.53
60.07
47.21
30.70
34.73
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
-0.56
-2.33
-1.02
-0.23
-1.54
-0.51
-2.70
Employee Cost
19.44
16.90
12.99
11.71
9.81
8.98
5.75
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.01
-0.01
0.01
0.00
0.00
3.06
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
23.37
22.73
18.98
13.59
12.34
9.87
2.83
Total Expenditure (Excl Depreciation)
100.43
96.95
84.47
85.15
67.82
49.04
43.67
Operating Profit (PBDIT) excl Other Income
20.86
27.20
22.69
33.57
38.85
10.32
7.02
Other Income
2.53
1.27
1.45
0.63
0.54
0.63
0.44
Operating Profit (PBDIT)
23.39
28.47
24.14
34.20
39.39
10.95
7.46
Interest
0.72
0.83
0.49
1.08
1.18
1.73
1.71
Exceptional Items
0.00
0.00
0.00
0.00
0.09
0.26
0.00
Gross Profit (PBDT)
22.67
27.64
23.65
33.12
38.30
9.48
5.76
Depreciation
3.32
2.49
1.89
1.83
1.38
1.35
1.31
Profit Before Tax
19.33
25.15
21.76
31.30
36.93
8.12
4.45
Tax
4.83
6.34
5.38
7.89
9.30
2.23
1.22
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
14.50
18.82
16.38
23.40
27.62
5.89
3.23
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
14.50
18.82
16.38
23.40
27.62
5.89
3.23
Share in Profit of Associates
2.98
1.03
3.51
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
-1.64
-0.66
-0.63
0.09
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
17.48
19.85
19.89
20.35
26.57
5.14
3.14
Equity Capital
8.26
8.26
8.26
8.26
8.26
8.26
8.26
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Diluted Earnings per share
5.31
8.68
3.95
6.33
8.02
2.13
1.1
Operating Profit Margin (Excl OI)
17.2%
21.91%
21.17%
28.28%
36.42%
17.39%
13.85%
Gross Profit Margin
18.69%
22.26%
22.07%
27.9%
35.91%
15.97%
11.36%
PAT Margin
11.95%
15.16%
15.29%
19.71%
25.89%
9.92%
6.38%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Nine Monthly Analysis Highlights
Net Sales
YoY Growth in nine months ended Dec 2024 is -2.30% vs 15.85% in Dec 2023
Consolidate Net Profit
YoY Growth in nine months ended Dec 2024 is -11.94% vs -0.20% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in nine months ended Dec 2024 is -23.31% vs 19.88% in Dec 2023
Interest
YoY Growth in nine months ended Dec 2024 is -13.25% vs 69.39% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in nine months ended Dec 2024 has fallen from Dec 2023
Compare Nine Monthly Results Of Titan Biotech With
Figures in Rs cr
Consolidate Nine Monthly Results
Change(INR)
Change(%)
Net Sales
121.29
6,102.24
-5,980.95
-98.01%
Other Operating Income
0.00
0.00
0.00
Total Operating income
121.29
6,102.24
-5,980.95
-98.01%
Raw Material Cost
58.18
4,201.93
-4,143.75
-98.62%
Purchase of Finished goods
0.00
113.16
-113.16
-100.00%
(Increase) / Decrease In Stocks
-0.56
-39.56
39.00
98.58%
Employee Cost
19.44
290.57
-271.13
-93.31%
Power Cost
0.00
349.07
-349.07
-100.00%
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
23.37
411.82
-388.45
-94.33%
Total Expenditure (Excl Depreciation)
100.43
5,326.99
-5,226.56
-98.11%
Operating Profit (PBDIT) excl Other Income
20.86
775.25
-754.39
-97.31%
Other Income
2.53
61.07
-58.54
-95.86%
Operating Profit (PBDIT)
23.39
836.32
-812.93
-97.20%
Interest
0.72
18.16
-17.44
-96.04%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
22.67
818.16
-795.49
-97.23%
Depreciation
3.32
144.13
-140.81
-97.70%
Profit Before Tax
19.33
674.03
-654.70
-97.13%
Tax
4.83
179.17
-174.34
-97.30%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
14.50
494.86
-480.36
-97.07%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
14.50
494.86
-480.36
-97.07%
Share in Profit of Associates
2.98
0.00
2.98
Minority Interest
0.00
0.04
-0.04
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
17.48
494.82
-477.34
-96.47%
Equity Capital
8.26
27.28
-19.02
-69.72%
Face Value
10.00
2.00
0.00
Reserves
0.00
0.00
0.00
Gross Profit Margin
18.69%
13.41%
0.00
5.28%
PAT Margin
11.95%
8.11%
0.00
3.84%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 121.29 Cr
in Dec 2024Figures in Rs Cr
YoY Growth in nine months ended Dec 2024 is -2.30% vs 15.85% in Dec 2023
Nine Monthly - Consolidate Net Profit
Consolidate Net Profit 17.48 Cr
in Dec 2024Figures in Rs Cr
YoY Growth in nine months ended Dec 2024 is -11.94% vs -0.20% in Dec 2023
Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 20.86 Cr
in Dec 2024Figures in Rs Cr
YoY Growth in nine months ended Dec 2024 is -23.31% vs 19.88% in Dec 2023
Nine Monthly - Interest
Interest 0.72 Cr
in Dec 2024Figures in Rs Cr
YoY Growth in nine months ended Dec 2024 is -13.25% vs 69.39% in Dec 2023
Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 17.20%
in Dec 2024Figures in Rs %
YoY Growth in nine months ended Dec 2024 has fallen from Dec 2023
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
